Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Xuedan Zhu"'
Autor:
Xuedan Zhu, Xinke Zhang, Yuqing Zhang, Jiahao Li, Siqi Li, Siqi Zhang, Li Li, Li Meng, Hengxi Wei, Shouquan Zhang
Publikováno v:
Frontiers in Veterinary Science, Vol 11 (2024)
This study aimed to determine the effect of prostaglandin F2α (PGF2α) analog (D-cloprostenol sodium and DL-cloprostenol sodium) administration on the milk yield of multiparous sows (MS) and piglet growth performance. In total, 320 Landrace×Yorkshi
Externí odkaz:
https://doaj.org/article/fae3b0828e674d92bca40adf98dbf62e
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Reportedly, circular RNA (circRNA) is a key modulator in the development of human malignancies. This work is aimed to probe the expression pattern, biological effects and mechanism of circ_0064288 on hepatocellular carcinoma (HCC)
Externí odkaz:
https://doaj.org/article/fc7d77114aff4449a171d205a4dbdac3
Publikováno v:
Theriogenology. 192:28-37
Publikováno v:
Journal of Materials Science. 57:18787-18805
Autor:
Yinxing Zhu, Yixuan Hu, Xuedan Zhu, Juan Zhang, Daolu Yuwen, Xiaowei Wei, Cuiju Tang, Wenwen Zhang
Publikováno v:
Carcinogenesis. 43:736-745
To improve the early detection of gastric cancer (GC), there is a growing need for novel and efficient biomarkers. We aimed to evaluate diagnostic value of thioredoxin reductase 1 (TXNRD1), which was found to be over expressed in various malignancies
Publikováno v:
Journal of Colloid and Interface Science. 616:287-297
Autor:
Yi, Chen, Xiao, Li, Jin, Xu, Hua, Xiao, Cuiju, Tang, Wei, Liang, Xuedan, Zhu, Yueyu, Fang, Hanjin, Wang, Junfeng, Shi
Publikováno v:
Bioengineered. 13:3526-3536
The burden of breast cancer (BC) has exacerbated over decades. Paclitaxel resistance is responsible for increasing BC treatment burden. Nuclear receptor binding SET domain-containing protein 1 (NSD1) is positively correlated with a poor prognosis in
Publikováno v:
Journal of Oncology Pharmacy Practice. 28:1435-1440
Introduction At present, the prognosis of HER2-positive advanced gastric cancer is extremely poor, and some patients fail to benefit from first-line Herceptin treatment, thus facing difficulties in choosing second-line drugs. Case Report Here, we rep
Autor:
Yi Chen, Weiwei Tang, Xuedan Zhu, Lele Zhang, Yinxing Zhu, Hua Xiao, Jin Xu, Yueyu Fang, Xiao Li, Cuiju Tang, Junfeng Shi
Publikováno v:
Bioengineered
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 2, Pp 11506-11519 (2021)
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 2, Pp 11506-11519 (2021)
Breast cancer (BC) is regarded as the major cause of cancer-associated deaths in women. Paclitaxel exerts a critical impact on the chemotherapy of BC, but the resistance to paclitaxel becomes a great obstacle in treating the disease. It is reported t
Autor:
Yinxing Zhu, Dongying Gu, Manman Chen, Yang Gong, Nan Chen, Xuedan Zhu, Xiaowen Cui, Han Yang, Xinying Huo, Jiali Dai, Cuiju Tang, Huanhuan Huang
Publikováno v:
The International Journal of Biological Markers. 36:28-35
Background: Circulating tumor cells and serum tumor markers have been found significant in predicting outcome for several malignancies. However, their role in gastric cancer is not fully clarified. We conducted a retrospective study to explore the pr